Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Change in Account Payables (2016 - 2025)

Nephros (NEPH) has 12 years of Change in Account Payables data on record, last reported at $312000.0 in Q3 2025.

  • For Q3 2025, Change in Account Payables rose 140.73% year-over-year to $312000.0; the TTM value through Sep 2025 reached $545000.0, up 233.25%, while the annual FY2024 figure was -$220000.0, 265.41% down from the prior year.
  • Change in Account Payables reached $312000.0 in Q3 2025 per NEPH's latest filing, up from $81000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $685000.0 in Q4 2021 and bottomed at -$766000.0 in Q3 2024.
  • Average Change in Account Payables over 5 years is $27157.9, with a median of $68000.0 recorded in 2023.
  • Peak YoY movement for Change in Account Payables: tumbled 675.0% in 2022, then surged 1261.9% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $685000.0 in 2021, then crashed by 105.55% to -$38000.0 in 2022, then soared by 278.95% to $68000.0 in 2023, then soared by 277.94% to $257000.0 in 2024, then increased by 21.4% to $312000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were $312000.0 in Q3 2025, $81000.0 in Q2 2025, and -$105000.0 in Q1 2025.